UKs health regulator has imposed restrictions on import of medicines made at Wockhardts unit at Kadaiya in Nani Daman for violation of norms.
The Medicines and Healthcare Products Regulatory Agency, UK UKMHRA has decided to withdraw the previously issued GMP Certificate to the companys manufacturing facility situated at Kadaiya,Nani Daman,in Daman in Diu,Wockhardt said in a filing to the BSE.
This is the third plant of the company facing UKMHRA action after its Chikalthana facility in Maharashtra,from where good manufacturing certification was withdrawn last week,and the export-oriented plant at Waluj which came under an import alert in July this year.
The UKMHRA will be issuing a restricted GMP certificate to the site along with a statement of non-compliance for the site.
The scope of the statement of non-compliance is therefore limited to medicinal products considered non- critical to public health, the filing added.